InsidersTradesSigma
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Lehr Martin A., Chief Executive Officer. Insider active across 1 companies, notably Context Therapeutics Inc.. Cumulatively, 6 reports have been logged. Total volume traded: €160k. The latest transaction was filed on 16 December 2021 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
€37,06513,000 shares@ €2.85129.2% of flow
Common Stock
SEC:0001842952-21-000029·
Ideal exit: 12 Sept 2022 (T+270)
€37,06513,000 shares@ €2.85120.019% mcap4.6% of flow
Common Stock
SEC:0001842952-21-000029:0·
Ideal exit: 12 Sept 2022 (T+270)
€323,54852,680 shares@ €6.141880.2% of flow
Common Stock
SEC:0001842952-21-000027·
€323,54852,680 shares@ €6.14180.16% mcap40.1% of flow
Common Stock
SEC:0001842952-21-000027:0·
€43,00910,000 shares@ €4.300910.7% of flow
Common Stock
SEC:0001179110-21-009609·
Ideal exit: 19 Jul 2022 (T+270)
€43,00910,000 shares@ €4.30090.022% mcap5.3% of flow
Common Stock
SEC:0001179110-21-009609:0·
Ideal exit: 19 Jul 2022 (T+270)
6 of 6 declarations
About Lehr Martin A.
Martin A. Lehr is the Chief Executive Officer of Context Therapeutics Inc. He leads the company's operations and oversees strategic initiatives to ensure its growth in the biopharmaceutical sector. His leadership is essential for navigating a dynamic environment.
